Skip to content

Checked

Class IDrug recallTerminated

Finasteride Plus 1.25 mg Capsule recall

Recalled by MasterPharm LLC of South Richmond Hill, NY · FDA report 05/20/2020

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class I
Most serious
Status
Terminated
Closed 09/07/2023
Recall started
04/14/2020
Distribution
Nationwide

Reason for recall

Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

Class I: A reasonable chance that using or being exposed to the product will cause serious health problems or death.

Recalled product

Product
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
Lot and code info
Lot #02-27-2020:04@11, Exp. August 25, 2020.
Quantity
7260 capsules
Recall number
D-1269-2020
Event ID
85619
Initiated by
Voluntary: Firm initiated

Where it was distributed

Nationwide in the U.S.

  • Nationwide

Recall timeline

  1. 04/14/2020Firm started the recall
  2. 05/19/2020FDA classified it as Class I
  3. 05/20/2020Published in the FDA enforcement report
  4. 09/07/2023FDA closed (terminated) the recall

More recalls from MasterPharm

Frequently asked questions

Why was Finasteride Plus 1.25 mg Capsule recalled?
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
What does Class I mean?
Class I is FDA's most serious recall category: a reasonable chance that using or being exposed to the product will cause serious health problems or death.
Where was the recalled product sold?
Nationwide in the U.S.
Is this recall still active?
The FDA lists the recall as terminated (closed 09/07/2023). FDA has determined the recall is complete and closed it.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 05/20/2020 · Do not rely on openFDA to make decisions regarding medical care